These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23733445)

  • 1. Chemistry and biology of the potent endotoxin from a Burkholderia dolosa clinical isolate from a cystic fibrosis patient.
    Lorenzo FD; Sturiale L; Palmigiano A; Lembo-Fazio L; Paciello I; Coutinho CP; Sá-Correia I; Bernardini M; Lanzetta R; Garozzo D; Silipo A; Molinaro A
    Chembiochem; 2013 Jun; 14(9):1105-15. PubMed ID: 23733445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure and proinflammatory activity of the lipopolysaccharide from Burkholderia multivorans and the differences between clonal strains colonizing pre and posttransplanted lungs.
    Ieranò T; Silipo A; Sturiale L; Garozzo D; Brookes H; Khan CM; Bryant C; Gould FK; Corris PA; Lanzetta R; Parrilli M; De Soyza A; Molinaro A
    Glycobiology; 2008 Nov; 18(11):871-81. PubMed ID: 18684854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First structural characterization of Burkholderia vietnamiensis lipooligosaccharide from cystic fibrosis-associated lung transplantation strains.
    Ieranò T; Silipo A; Sturiale L; Garozzo D; Bryant C; Lanzetta R; Parrilli M; Aldridge C; Gould FK; Corris PA; Khan CM; De Soyza A; Molinaro A
    Glycobiology; 2009 Nov; 19(11):1214-23. PubMed ID: 19641092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity.
    De Soyza A; Ellis CD; Khan CM; Corris PA; Demarco de Hormaeche R
    Am J Respir Crit Care Med; 2004 Jul; 170(1):70-7. PubMed ID: 15044201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity.
    Di Lorenzo F; Silipo A; Bianconi I; Lore' NI; Scamporrino A; Sturiale L; Garozzo D; Lanzetta R; Parrilli M; Bragonzi A; Molinaro A
    Mol Immunol; 2015 Feb; 63(2):166-75. PubMed ID: 24856407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.
    Caraher E; Duff C; Mullen T; Mc Keon S; Murphy P; Callaghan M; McClean S
    J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315).
    Silipo A; Molinaro A; Ieranò T; De Soyza A; Sturiale L; Garozzo D; Aldridge C; Corris PA; Khan CM; Lanzetta R; Parrilli M
    Chemistry; 2007; 13(12):3501-11. PubMed ID: 17219455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vizantin inhibits endotoxin-mediated immune responses via the TLR 4/MD-2 complex.
    Oda M; Yamamoto H; Shibutani M; Nakano M; Yabiku K; Tarui T; Kameyama N; Shirakawa D; Obayashi S; Watanabe N; Nakase H; Suenaga M; Matsunaga Y; Nagahama M; Takahashi H; Imagawa H; Kurosawa M; Terao Y; Nishizawa M; Sakurai J
    J Immunol; 2014 Nov; 193(9):4507-14. PubMed ID: 25261480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.
    Kalish LA; Waltz DA; Dovey M; Potter-Bynoe G; McAdam AJ; Lipuma JJ; Gerard C; Goldmann D
    Am J Respir Crit Care Med; 2006 Feb; 173(4):421-5. PubMed ID: 16272450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.
    Roux D; Weatherholt M; Clark B; Gadjeva M; Renaud D; Scott D; Skurnik D; Priebe GP; Pier G; Gerard C; Yoder-Himes DR
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28348057
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R; Spilker T; Lipuma JJ
    J Clin Microbiol; 2005 Jun; 43(6):2926-8. PubMed ID: 15956421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia cepacia complex species: health hazards and biotechnological potential.
    Chiarini L; Bevivino A; Dalmastri C; Tabacchioni S; Visca P
    Trends Microbiol; 2006 Jun; 14(6):277-86. PubMed ID: 16684604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
    Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
    J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4.
    Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS
    Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients.
    Desai AP; Stanley T; Atuan M; McKey J; Lipuma JJ; Rogers B; Jerris R
    J Clin Pathol; 2012 Sep; 65(9):835-8. PubMed ID: 22639406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry.
    Miñán A; Bosch A; Lasch P; Stämmler M; Serra DO; Degrossi J; Gatti B; Vay C; D'aquino M; Yantorno O; Naumann D
    Analyst; 2009 Jun; 134(6):1138-48. PubMed ID: 19475140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFkappaB.
    Bamford S; Ryley H; Jackson SK
    Cell Microbiol; 2007 Feb; 9(2):532-43. PubMed ID: 17002785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.